MedTrace Logo

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer

NCT01326286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3265

Last updated 2018-09-26

No results posted yet for this study

Summary

This study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer. It will focus on modern technologies and control for differences in patients and treatments that may affect both cancer-related and patient-reported outcomes (such as impotence and incontinence). By figuring out what treatments "work best, in which patients and in whose hands", it will help men with prostate cancer make better decisions regarding their care.

Conditions

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Louisiana State University Health Sciences Center in New Orleans

    collaborator OTHER

  • University of California, Irvine

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • David F Penson, MD, MPH · Vanderbilt University

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2017-08-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01326286 on ClinicalTrials.gov